MP36-07 TRANSRECTAL ULTRASOUND GUIDED ASPIRATION VERSUS TRANSURETHRAL DEROOFING OF PROSTATIC ABSCESS: A PROSPECTIVE RANDOMIZED STUDY

Abstract

You have accessJournal of UrologyInfections/Inflammation/Cystic Disease of the Genitourinary Tract: Prostate & Genitalia II1 Apr 2016MP36-07 TRANSRECTAL ULTRASOUND GUIDED ASPIRATION VERSUS TRANSURETHRAL DEROOFING OF PROSTATIC ABSCESS: A PROSPECTIVE RANDOMIZED STUDY Mohammed Seleem, Esam Desoky, Ahmed Eliwa, Mostafa Youssef, Mohamed Omran, Ehab Elkady, Ahmed Sakr, and Amr Fawzi Mohammed SeleemMohammed Seleem More articles by this author , Esam DesokyEsam Desoky More articles by this author , Ahmed EliwaAhmed Eliwa More articles by this author , Mostafa YoussefMostafa Youssef More articles by this author , Mohamed OmranMohamed Omran More articles by this author , Ehab ElkadyEhab Elkady More articles by this author , Ahmed SakrAhmed Sakr More articles by this author , and Amr FawziAmr Fawzi More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.1641AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The aim of this study is to compare between transrectal ultrasound (TRUS) guided aspiration and transurethral deroofing in treatment of prostatic abscess regarding safety and efficacy. METHODS This prospective randomized study was done during the period between April 2009 and March 2015 and included 32 patients with prostatic abscess. All patients were enrolled in the study after obtaining a written informed consent and approval of the local ethical committee. The patients were randomly allocated into two groups; Group A treated by TRUS guided aspiration, saline wash and local injection of antibiotics and group B treated by transurethral deroofing of the abscess. All patients received broad spectrum antibiotics during the period of treatment and follow up was done on the fifth day by TRUS to ensure complete resolution of the abscess. RESULTS Mean age was 59±11.46 and 60±13.65 years for groups A and B respectively. Diabetes mellitus was detected in 9 (56.25%) and 6 (37.5%) patients in groups A and B respectively, hypertension in 7 (43.75%) and 6 (37.5%) patients in groups A and B respectively and two patients (12.5%) with liver cirrhosis in each group. The mean size of the abscess was 3.36±0.86 and 3.04±0.86 cm in groups A and B respectively (p=0.29). The abscess recurred in 5 patients (31.25%) and in one patient (6.25%) in groups A and B respectively (p=0.08). TRUS guided aspiration was done for all recurrent cases except for 2 patients (12.5%) in group A required trans urethral deroofing of the recurrent abscess. The mean hospital stay was 12.9±4.05 and 7.25±2.40 days for groups A and B respectively (p=0.000). In group A one patient (6.25%) was complicated by urethrorectal fistula, while in group B one patient (6.25%) was complicated by septic shock, three patients (13.75%) with epididmoorchitis and two patients (12.5%) with urethral stricture. CONCLUSIONS Patients with prostatic abscess treated with TRUS guided aspiration show less morbidity, higher recurrence rate and longer hospital stay than those treated with transurethral deroofing © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e491-e492 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Mohammed Seleem More articles by this author Esam Desoky More articles by this author Ahmed Eliwa More articles by this author Mostafa Youssef More articles by this author Mohamed Omran More articles by this author Ehab Elkady More articles by this author Ahmed Sakr More articles by this author Amr Fawzi More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...